Chiesa G - Search Results

1

Targeted replacement of mouse apolipoprotein A-I with human ApoA-I or the mutant ApoA-IMilano. Evidence of APOA-IM impaired hepatic secretion.

Parolini C, Chiesa G, Zhu Y, Forte T, Caligari S, Gianazza E, Sacco MG, Sirtori CR, Rubin EM. Parolini C, et al. Among authors: chiesa g. J Biol Chem. 2003 Feb 14;278(7):4740-6. doi: 10.1074/jbc.M207335200. Epub 2002 Dec 5. J Biol Chem. 2003. PMID: 12471038 Free article.

2

Atherogenesis in transgenic mice expressing human apolipoprotein(a).

Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM. Lawn RM, et al. Among authors: chiesa g. Nature. 1992 Dec 17;360(6405):670-2. doi: 10.1038/360670a0. Nature. 1992. PMID: 1465128

3

Activity profile of gemfibrozil on the major plasma lipoprotein parameters.

Sirtori CR, Franceschini G, Gianfranceschi G, Vaccarino V, Chiesa G, Maderna P, Bertoli M, Calabresi L. Sirtori CR, et al. Among authors: chiesa g. Eur J Epidemiol. 1992 May;8 Suppl 1:120-4. doi: 10.1007/BF00145362. Eur J Epidemiol. 1992. PMID: 1505648 Clinical Trial.

4

Predictability of low-density lipoprotein levels during apheretic treatment of hypercholesterolaemia.

Franceschini G, Busnach G, Calabresi L, Chiesa G, Gianfranceschi G, Zoppi F, Minetti L, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Eur J Clin Invest. 1991 Apr;21(2):209-14. doi: 10.1111/j.1365-2362.1991.tb01811.x. Eur J Clin Invest. 1991. PMID: 1905633

5

Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients.

Franceschini G, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Eur J Clin Invest. 1991 Aug;21(4):384-8. doi: 10.1111/j.1365-2362.1991.tb01385.x. Eur J Clin Invest. 1991. PMID: 1936105

6

Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresis.

Franceschini G, Busnach G, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Am J Med. 1991 May;90(5):633-8. Am J Med. 1991. PMID: 2029022

7

In vitro activity of probucol on cholesteryl ester transport.

Chiesa G, Franceschini G, Sirtori CR. Chiesa G, et al. Biochim Biophys Acta. 1990 Aug 6;1045(3):302-4. doi: 10.1016/0005-2760(90)90135-k. Biochim Biophys Acta. 1990. PMID: 2386803

8

Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.

Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. J Lab Clin Med. 1989 Sep;114(3):250-9. J Lab Clin Med. 1989. PMID: 2504855 Clinical Trial.

9

Effects of probucol on the high density lipoprotein system in hypercholesterolaemic patients.

Franceschini G, Calabresi L, Chiesa G, Vaccarino V, Sirtori M, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Pharmacol Res. 1989 Jan-Feb;21(1):113-4. doi: 10.1016/1043-6618(89)90139-4. Pharmacol Res. 1989. PMID: 2726655 No abstract available.

10

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.

Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Arteriosclerosis. 1989 Jul-Aug;9(4):462-9. doi: 10.1161/01.atv.9.4.462. Arteriosclerosis. 1989. PMID: 2751476 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters